United States Non-Invasive Glucose Monitoring Devices Market Grows at 7.5% CAGR as Wearable Sensors and Needle-Free Diabetes Care Gain Momentum

Leander, Texas and Tokyo, Japan - Jan.12.2026
As per DataM Intelligence research report " global non-invasive glucose monitoring devices market reached US$ 29.53 Million in 2023, with a rise of US$ 31.57 Million in 2024 and is expected to reach US$ 60.71 Million by 2033, growing at a CAGR of 7.5% from 2025 to 2033." Rising global diabetes prevalence, patient preference for pain-free needle-free technologies, advancements in sensor and wearable innovations, and focus on real-time continuous monitoring are fueling growth in the non-invasive glucose monitoring devices market.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/non-invasive-glucose-monitoring-devices-market?sindhuri

Japan: Recent Industry Developments
✅ In 2025, Japanese researchers and companies advanced wearable optical and transdermal sensor technologies, supporting integration into smart health devices for aging populations and diabetes management.
✅ In 2025, Government initiatives under Japan's health tech roadmap promoted R&D in non-invasive monitoring to reduce burden on elderly diabetics, with partnerships exploring Raman spectroscopy and AI-enhanced accuracy.
✅ In 2025, Collaborations with global players focused on regulatory pathways for emerging non-invasive CGM solutions tailored to Japan's high diabetes awareness and tech adoption.

United States: Recent Industry Developments
✅ In June 2025, Garmin filed a patent for non-invasive glycated haemoglobin estimation in smartwatches, advancing wearable continuous monitoring capabilities.
✅ In February 2025, Afon Technology launched Glucowear, the world's first non-invasive real-time glucose sensor, targeting seamless integration for diabetes patients.
✅ In February 2024 (with ongoing 2025 progress), Know Labs unveiled KnowU, a wearable non-invasive CGM system, pursuing FDA clearance and expanding clinical validation.

Non-invasive Glucose Monitoring Devices Market: Drivers
The non-invasive glucose monitoring devices market is driven by the escalating global diabetes burden, with over 537 million adults affected in 2023, projected to reach 783 million by 2045 due to urbanization, aging populations, sedentary lifestyles, and obesity. Patient demand for painless, needle-free alternatives reduces discomfort, improves adherence, and enables real-time tracking via wearables and apps. Technological progress in optical, electromagnetic, and thermal sensors, along with supportive policies for digital health and remote monitoring, further accelerate adoption amid rising preventive care focus.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/non-invasive-glucose-monitoring-devices-market?sindhuri

Non-invasive Glucose Monitoring Devices Market: Major Players
Know Labs, Inc., Conga Medical Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Medtronic, Abbott Laboratories, Dexcom, Inc., Afon Technology, Ascensia Diabetes Care, BlueSemi.

Segment Covered in the Non-invasive Glucose Monitoring Devices Market:
By Product Type
Wearable Devices (holding ~51.33% share), Non-wearable Devices.
By Technology
Optical, Transdermal, Enzymatic, Electromagnetic, Thermal, Ultrasound.
By Application
Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes.
By End User
Hospitals & Clinics, Home Care Settings, Diagnostic Centers, Research Institutes.

Regional Analysis
North America - Dominant Share
North America leads (valued at US$ 13.2 million in 2024) with high diabetes prevalence (over 37 million in US), advanced infrastructure, reimbursement support, FDA initiatives, and strong adoption of remote monitoring post-COVID.
Asia Pacific - Fastest-Growing
Asia Pacific expands rapidly (valued at US$ 7.41 million in 2024) due to over 60% of global diabetic population, urbanization-driven type 2 rise, government programs (e.g., India's Ayushman Bharat, China's Healthy China 2030), and growing middle-class access.
Europe - Significant Share
Europe grows with emphasis on innovative sensors and regulatory support for diabetes tech.
South America - Gradual Growth
South America shows steady progress amid increasing diabetes awareness and healthcare improvements.
Middle East & Africa - Emerging Growth
Middle East & Africa rises with investments in chronic disease management and digital health.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=non-invasive-glucose-monitoring-devices-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.